key: cord-0861091-lrm6108e
authors: Dalan, Rinkoo; Boehm, Bernhard O.
title: Reply - Letter to the editor: “Micronutrient supplementation,COVID-19 vaccination and adverse effect”
date: 2022-03-04
journal: Clin Nutr ESPEN
DOI: 10.1016/j.clnesp.2022.02.117
sha: b754bba0b91ee6300bc4eb3abe1eb9138b955442
doc_id: 861091
cord_uid: lrm6108e

nan

Reply -Letter to the editor : "Micronutrient supplementation,COVID-19 vaccination and adverse effect" 1 We wish to highlight that data specific to the safety and efficacy of COVID-19 vaccines, in thalassemia patients is limited. However, there is significant data to show that COVID infection in thalassemia is associated with significant mortality (>25%). 2, 3 Hence, most international guidelines suggest that the benefits of COVID-19 immunization outweigh any theoretical risks of immunization. 4 With regards to genetic polymorphisms like vitamin D genetic polymorphisms, specific data on the safety and efficacy of COVID-19 vaccines, is limited. However, there is evidence to show that individuals with vitamin D genetic polymorphisms and other polymorphisms in the vitamin D metabolism pathway, are at increased risk for COVID-19 infection severity and mortality. 5, 6 There is also evidence to show low pre-infection 25(OH)D concentrations is associated with increased risk of COVID-19 infection severity and mortality. 7 Hence, the benefits of COVID-19 immunization will outweigh any theoretical risks of immunization regardless of underlying vitamin D related genetic polymorphisms and vitamin D deficiency. Moreover, vitamin D supplementation to maintain adequate 25(OH)D concentrations has been suggested to reduce the risk of COVID-19 transmission and infection. 8 We wish to highlight that while we suggest that supplementation will be useful in susceptible patients to reduce the risk of adverse effects in terms of autoimmune re-activation and thrombosis potential with COVID-19 vaccinations, these adverse effects are relatively rare. Hence, we would like to stress on the importance of COVID-19 immunization in the population.

The author declares no potential conflict of interest.

Micronutrient supplementation, COVID-19 vaccination and adverse effect: correspondence

Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience

β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study

TIF Position Statement on the COVID-19 Vaccines & Haemoglobinopathies

Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19

Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents

Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness

Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review